logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2020 — Is there a role for trabectedin in ovarian cancer progressing after platinum treatment?

Prolonging the platinum-free interval using trabectedin after recurrence failed to improve overall survival compared to carboplatin.